1:51 PM
Oct 10, 2017
 |  BC Innovations  |  Distillery Therapeutics


Editor's Note: This article was updated on Oct 11, 2017 at 8:40 AM PDT


Patient sample, cell culture and mouse studies suggest blocking the interaction of miR-16 and TYRP1 mRNA could help treat melanoma. In melanoma patients, the absence of the low-expressing TYRP1-A...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >